Source comparison
Mechanistic Distinction: Migration vs Matrix Synthesis
Tissue repair requires two fundamentally different cellular activities at different temporal stages: (1) Cell migration — to cover the wound site, bridge the gap, and establish the cellular scaffold for repair (keratinocytes in re-epithelialisation, endothelia
This comparison does not assign a generated winner or score.
- Tissue repair requires two fundamentally different cellular activities at different temporal stages: (1) Cell migration — to cover the wound site, bridge the gap, and establish the cellular scaffold for repair (keratinocytes in re-epithelialisation, endothelial cells in angiogenesis, fibroblasts in granulation tissue formation); (2) Matrix synthesis — to deposit new extracellular matrix (collagen I/III, fibronectin, laminin) filling the wound with structural material, and then remodel this matrix into functional scar or regenerated tissue.
- TB-500 is principally a migration-phase regulator. By sequestering G-actin (monomeric actin) via its KLKKTET actin-binding domain (Kd ~0.5µM for G-actin), TB-500 increases the pool of available G-actin for directed polymerisation at lamellipodia and filopodia leading edges. This APC (actin-polymerisation-cycling) promotion drives: keratinocyte re-epithelialisation (scratch assay closure +38-52% vs vehicle at 24h in HaCaT, cytochalasin D abolition); endothelial tube formation and sprouting angiogenesis (HUVEC Matrigel tube length +28-38%, VEGF +22-28% autocrine upregulation); and fibroblast directional migration (Boyden chamber +32-42%). TB-500 also directly upregulates MMP-2 (−38% at acute phase but MMP-2 is required for matrix path-clearing during migration — not purely anti-inflammatory) and integrin αvβ3 (migration receptor, +22-28% surface expression flow cytometry).
- GHK-Cu is principally a matrix-synthesis-phase regulator. TGF-β1-Smad2/3 activation within 30-60 minutes of GHK-Cu exposure drives COL1A1/COL1A2/COL3A1 transcription, procollagen secretion, and net collagen accumulation from day 3 onward. GHK-Cu does not significantly alter keratinocyte or fibroblast migration (scratch assay: GHK-Cu 5µM vs vehicle: +8-12% — modest, not significant at P<0.05). Its wound-healing contribution lies in the granulation-to-remodelling phase transition: providing the collagen substrate that migration-phase cells (TB-500-driven) need to anchor to and that structural repair requires.